Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
18.33
-1.19 (-6.10%)
At close: May 9, 2025, 4:00 PM
18.33
0.00 (0.00%)
After-hours: May 9, 2025, 4:00 PM EDT

Celldex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1,2181,6772,1692,0991,803693
Upgrade
Market Cap Growth
-55.44%-22.71%3.32%16.42%160.10%1759.97%
Upgrade
Enterprise Value
5719241,9361,7791,383497
Upgrade
Last Close Price
19.5225.2739.6644.5738.6417.52
Upgrade
PS Ratio
171.14238.82315.12890.64387.6893.45
Upgrade
PB Ratio
1.842.245.056.444.303.31
Upgrade
P/TBV Ratio
1.842.335.407.024.603.88
Upgrade
EV/Sales Ratio
75.55131.57281.34754.94297.3767.06
Upgrade
Debt / Equity Ratio
0.010.010.010.010.010.02
Upgrade
Asset Turnover
0.010.010.020.010.010.04
Upgrade
Quick Ratio
21.0618.3813.6916.4124.7113.81
Upgrade
Current Ratio
21.6718.9213.8717.0724.8613.93
Upgrade
Return on Equity (ROE)
-23.20%-26.84%-37.45%-30.13%-22.43%-39.41%
Upgrade
Return on Assets (ROA)
-16.88%-19.38%-21.70%-16.79%-12.70%-17.27%
Upgrade
Return on Capital (ROIC)
-17.55%-20.62%-23.30%-17.78%-13.60%-19.96%
Upgrade
Earnings Yield
-14.41%-9.42%-6.52%-5.35%-3.91%-8.62%
Upgrade
FCF Yield
-13.97%-9.53%-5.03%-5.03%-3.45%-6.05%
Upgrade
Buyback Yield / Dilution
-29.03%-32.91%-3.33%-9.37%-44.64%-104.31%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q